In the present study, we assessed the underlying molecular mechanisms using an in vitro model of human cancer cell lines, with differential expression of MRP4, based on the hypothesis that R-flurbiprofen, which has been shown to interfere with organic anion transporters (OATs), may target MRP4-mediated PG transport. The gene discussed is ABCC4; the disease is cancer.